Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M82,421Revenue $M19,616Net Margin (%)11.2Altman Z-Score3.9
Enterprise Value $M86,528EPS $2.2Operating Margin %16.0Piotroski F-Score4
P/E(ttm)36.2Beneish M-Score-2.6Pre-tax Margin (%)13.9Higher ROA y-yN
Price/Book5.210-y EBITDA Growth Rate %10.8Quick Ratio1.1Cash flow > EarningsY
Price/Sales4.05-y EBITDA Growth Rate %-6.0Current Ratio1.4Lower Leverage y-yN
Price/Free Cash Flow33.8y-y EBITDA Growth Rate %-32.9ROA % (ttm)6.2Higher Current Ratio y-yN
Dividend Yield %2.7PEG--ROE % (ttm)13.0Less Shares Outstanding y-yY
Payout Ratio %96.0Shares Outstanding M1,110ROIC % (ttm)13.7Gross Margin Increase y-yN

Gurus Latest Trades with LLY

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
LLYVanguard Health Care Fund 2015-03-31 Add0.45%$68.41 - $76.36
($71.19)
$ 74.274%Add 13.24%24,892,160
LLYCharles Brandes 2015-03-31 Reduce-0.06%$68.41 - $76.36
($71.19)
$ 74.274%Reduce 36.80%107,025
LLYKen Fisher 2015-03-31 Add0.03%$68.41 - $76.36
($71.19)
$ 74.274%Add 37.46%795,909
LLYHOTCHKIS & WILEY 2015-03-31 Add0.01%$68.41 - $76.36
($71.19)
$ 74.274%Add 0.70%3,968,039
LLYJoel Greenblatt 2015-03-31 Sold Out -0.0031%$68.41 - $76.36
($71.19)
$ 74.274%Sold Out0
LLYDodge & Cox 2015-03-31 Reduce$68.41 - $76.36
($71.19)
$ 74.274%Reduce 7.10%36,234
LLYMario Gabelli 2015-03-31 Reduce$68.41 - $76.36
($71.19)
$ 74.274%Reduce 1.76%111,800
LLYCharles Brandes 2014-12-31 Reduce-1.85%$61.9 - $72.83
($67.53)
$ 74.2710%Reduce 92.65%169,348
LLYRichard Pzena 2014-12-31 Sold Out -0.15%$61.9 - $72.83
($67.53)
$ 74.2710%Sold Out0
LLYKen Fisher 2014-12-31 Add0.07%$61.9 - $72.83
($67.53)
$ 74.2710%Add 383.26%578,992
LLYCharles Brandes 2014-09-30 Reduce-0.29%$60.35 - $66.59
($63.3)
$ 74.2717%Reduce 14.27%2,303,062
LLYHOTCHKIS & WILEY 2014-09-30 Reduce-0.12%$60.35 - $66.59
($63.3)
$ 74.2717%Reduce 10.92%4,321,666
LLYGeorge Soros 2014-09-30 Sold Out -0.02%$60.35 - $66.59
($63.3)
$ 74.2717%Sold Out0
LLYDavid Dreman 2014-09-30 Reduce-0.02%$60.35 - $66.59
($63.3)
$ 74.2717%Reduce 84.40%900
LLYKen Fisher 2014-09-30 Add0.02%$60.35 - $66.59
($63.3)
$ 74.2717%Add 2742.47%119,810
LLYJoel Greenblatt 2014-09-30 Reduce$60.35 - $66.59
($63.3)
$ 74.2717%Reduce 27.37%5,628
LLYDodge & Cox 2014-09-30 Add$60.35 - $66.59
($63.3)
$ 74.2717%Add 20.38%42,464
LLYHOTCHKIS & WILEY 2014-06-30 Add0.73%$58.21 - $63.1
($59.62)
$ 74.2725%Add 199.70%4,851,480
LLYVanguard Health Care Fund 2014-06-30 Reduce-0.15%$58.21 - $63.1
($59.62)
$ 74.2725%Reduce 3.98%21,982,700
LLYGeorge Soros 2014-06-30 Buy 0.02%$58.21 - $63.1
($59.62)
$ 74.2725%New holding50,441
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

LLY is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


LLY: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
LILLY ENDOWMENT INC10% Owner 2015-05-08Sell195,000$73.28-0.76view
LILLY ENDOWMENT INC10% Owner 2015-05-01Sell200,000$73.09-0.51view
LILLY ENDOWMENT INC10% Owner 2015-03-30Sell180,000$73.94-1.65view
LILLY ENDOWMENT INC10% Owner 2015-03-23Sell190,000$76.97-5.52view
Fry Stephen FSVP, HR & Diversity 2015-03-09Sell4,000$69.274.98view
Zakrowski Donald AChief Accounting Officer 2015-02-05Sell374$71.032.38view
Ricks David ASVP and Pres, Lilly Bio-Meds 2015-02-04Sell3,147$69.993.9view
Lundberg Jan MEVP,Science&Tech and Pres. LRL 2015-02-04Sell11,085$70.083.77view
Rice Derica WEVP-Global Services and CFO 2015-02-04Sell5,316$703.89view
Lundberg Jan MEVP,Science&Tech and Pres. LRL 2015-02-03Sell121,711$70.782.74view

Press Releases about LLY :

    Quarterly/Annual Reports about LLY:

    News about LLY:

    Articles On GuruFocus.com
    Biogen Making A Breakthrough In Treating Alzheimer’s May 02 2015 
    MannKind Looks Good For Long Term Investors Apr 29 2015 
    What Are The Intrinsic Factors Contributing To Pfizer’s Stock Movement? Mar 27 2015 
    Eli Lilly Inks Major Deal In China To Develop Oncology Segment Mar 23 2015 
    Box Inc. Declares Mixed Bag Q4 Results for 2015 Mar 13 2015 
    Primecap Management's Annual Shareholder Letter 2014 Mar 09 2015 
    FDA Approves Sanofi’s New Diabetes Drug Feb 27 2015 
    Feeling Good With This Med Company Jan 20 2015 
    Sarah Ketterer Dives in when Others Pull Out Nov 14 2014 
    Weekly 52-Week Highs Highlight: LLY, BG, NVS, HRL Sep 07 2014 

    More From Other Websites
    Eli Lilly & BioNTech Collaborate for Cancer Immunotherapies - Analyst Blog May 12 2015
    Lilly Announces Cash Tender Offer for Up to $1.6 Billion Aggregate Principal Amount of Its... May 12 2015
    8:33 am Eli Lilly announces a cash tender offer for $1.6 bln of various series of outstanding notes May 12 2015
    Lilly Announces Cash Tender Offer for Up to $1.6 Billion Aggregate Principal Amount of Its... May 12 2015
    Lilly and BioNTech Announce Research Collaboration on Novel Cancer Immunotherapies May 11 2015
    Lilly and BioNTech Announce Research Collaboration on Novel Cancer Immunotherapies May 11 2015
    The BBJ's top real estate stories of the week: May 8, 2015 May 08 2015
    Pence making China trip to drum up business for Indiana May 08 2015
    Healthcare Deals: Big Pharma, Megamergers and IPOs May 07 2015
    The Zacks Analyst Blog Highlights: Johnson & Johnson, Eli Lilly, iShares U.S. Pharmaceuticals ETF,... May 07 2015
    Under pressure, FDA to hold public meeting on off-label use May 06 2015
    LILLY ELI & CO Files SEC form 8-K, Submission of Matters to a Vote of Security Holders May 06 2015
    LILLY ELI & CO Financials May 06 2015
    Eli Lilly joins biotech stampede into Cambridge with new innovation center May 06 2015
    Big Pharma Q1 Earnings Beat Put Pharma ETFs in Focus - ETF News And Commentary May 06 2015
    Eli Lilly and Company Reveals Plan for Innovation Center in Cambridge, Massachusetts May 06 2015
    Eli Lilly and Company Reveals Plan for Innovation Center in Cambridge, Massachusetts May 06 2015
    Top Credit Suisse Major Pharma Stock Picks to Buy May 05 2015
    10-Q for Eli Lilly & Co. May 04 2015
    Vanguard Adds to Four of Its Largest Stakes May 04 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK